Abbott’s FreeStyle Libre 14 day system, which is used to identify continuous glucose levels, trends, and an eight-hour history of glucose patterns in diabetes patients, is pictured in this undated handout photo obtained by Reuters July 15, 2019. Abbott/Handout via REUTERS